FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065861 [Registered on: 16/04/2024] Trial Registered Prospectively
Last Modified On: 10/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Preventive 
Study Design  Other 
Public Title of Study   To study the effectiveness of tranexamic acid in reducing blood loss and postoperative complications in patients undergoing breast surgery 
Scientific Title of Study   Study of efficacy of tranexamic acid in reducing blood loss and postoperative complications in breast surgery  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Hariharan R 
Designation  Resident 
Affiliation  Govt Stanley medical college  
Address  7th floor I Block Department of General Surgery Govt Stanley medical college 1 old jail road George Town

Chennai
TAMIL NADU
600001
India 
Phone  9952559759  
Fax    
Email  hariharan.0101@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  B sathyapriya  
Designation  Professor 
Affiliation  Govt Stanley medical college  
Address  7 th floor I block Department of General Surgery Govt stanley medical college 1 old jail road George town

Chennai
TAMIL NADU
600001
India 
Phone  94444086644  
Fax    
Email  drbspriya@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Hariharan R 
Designation  Resident 
Affiliation  Govt Stanley medical college  
Address  Department of General Surgery Govt Stanley medical college 1 old jail road George Town


TAMIL NADU
600001
India 
Phone  9952559759  
Fax    
Email  hariharan.0101@gmail.com  
 
Source of Monetary or Material Support  
Govt Stanley medical college 1 old jail road George Town Chennai 600001 
 
Primary Sponsor  
Name  Dr Hariharan R  
Address  7th floor I block Department of general surgery Govt Stanley medical college 1 old jail road George Town Chennai 600 001  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Hariharan R   Govt Stanley medical college   Wing a, 8th floor,I BLOCK,department of General Surgery,Govt stanley medical college, 1,old jail road George Town
Chennai
TAMIL NADU 
9952559759

hariharan.0101@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Government Stanley medical college and hospital chennai 01 Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site, (2) ICD-10 Condition: D249||Benign neoplasm of unspecified breast,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  N/A  N/A 
Intervention  Tranaxemic acid  1 g Intravenous tranexamic acid preoperative and 3 doses in the 1st 24 hrs postoperative period  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Female 
Details  All females above 18 yrs of age undergoing breast surgery who consent to the study  
 
ExclusionCriteria 
Details  Patients not giving consent
Patients with uncontrolled comorbidities
History of prior thromboembolic events
Patients with severe renal impairment
Patients with seizure disorder
Patients with retinal vein occlusion  
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Effect of tranexamic acid in reducing postoperative bleeding
2 effect of tranexamic acid in reducing postoperative pain
3 effect of tranexamic acid in reducing other postoperative complications  
4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1 Effect of tranexamic acid in reducing other postoperative complications   4 weeks 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Aim to study the effect of tranexamic acid in reducing blood loss and postoperative complications in patients undergoing breast surgery
1g tranexamic acid will be given to the study group 1 dose preoperative and 3 doses in the 1st 24 hrs postoperative period and the postoperative pain and blood loss will be compared to the control group
 
Close